ILC3 function as a double-edged sword in inflammatory bowel diseases
Open Access
- 8 April 2019
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 10 (4), 1-12
- https://doi.org/10.1038/s41419-019-1540-2
Abstract
Inflammatory bowel diseases (IBD), composed mainly of Crohn’s disease (CD) and ulcerative colitis (UC), are strongly implicated in the development of intestinal inflammation lesions. Its exact etiology and pathogenesis are still undetermined. Recently accumulating evidence supports that group 3 innate lymphoid cells (ILC3) are responsible for gastrointestinal mucosal homeostasis through moderate generation of IL-22, IL-17, and GM-CSF in the physiological state. ILC3 contribute to the progression and aggravation of IBD while both IL-22 and IL-17, along with IFN-γ, are overexpressed by the dysregulation of NCR− ILC3 or NCR+ ILC3 function and the bias of NCR+ ILC3 towards ILC1 as well as regulatory ILC dysfunction in the pathological state. Herein, we feature the group 3 innate lymphoid cells’ development, biological function, maintenance of gut homeostasis, mediation of IBD occurrence, and potential application to IBD therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81172824)
This publication has 109 references indexed in Scilit:
- Group 3 Innate Lymphoid Cells Inhibit T-Cell-Mediated Intestinal Inflammation through Aryl Hydrocarbon Receptor Signaling and Regulation of MicrofloraImmunity, 2013
- Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteriaNature, 2013
- CX3CR1+ macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentiumMucosal Immunology, 2013
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- Functional Differences between Human NKp44− and NKp44+ RORC+ Innate Lymphoid CellsFrontiers in Immunology, 2012
- IL-23–responsive innate lymphoid cells are increased in inflammatory bowel diseaseThe Journal of Experimental Medicine, 2011
- Regulated Expression of Nuclear Receptor RORγt Confers Distinct Functional Fates to NK Cell Receptor-Expressing RORγt+ Innate LymphocytesImmunity, 2010
- Mesalamine Restores Angiogenic Balance in Experimental Ulcerative Colitis by Reducing Expression of Endostatin and Angiostatin: Novel Molecular Mechanism for Therapeutic Action of MesalamineThe Journal of pharmacology and experimental therapeutics, 2009
- New insights into the regulation of T cells by γc family cytokinesNature Reviews Immunology, 2009
- A human natural killer cell subset provides an innate source of IL-22 for mucosal immunityNature, 2008